The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer

BackgroundQualitative and quantitative changes in human mitochondrial DNA (mtDNA) have been implicated in various cancer types. A 4,977 bp deletion in the major arch of the mitochondrial genome is one of the most common mutations associated with a variety of human diseases and aging.MethodsWe conducted a comprehensive study on clinical features and mtDNA of 104 colorectal cancer patients in the Wenzhou area of China. In particular, using a quantitative real time PCR method, we analyzed the 4,977 bp deletion and mtDNA content in tumor tissues and paired non-tumor areas from these patients.ResultsWe found that the 4,977 bp deletion was more likely to be present in patients of younger age (≤65 years, p = 0.027). In patients with the 4,977 bp deletion, the deletion level decreased as the cancer stage advanced (p = 0.031). Moreover, mtDNA copy number in tumor tissues of patients with this deletion increased, both compared with that in adjacent non-tumor tissues and with in tumors of patients without the deletion. Such mtDNA content increase correlated with the levels of the 4,977 bp deletion and with cancer stage (p < 0.001).ConclusionsOur study indicates that the mtDNA 4,977 bp deletion may play a role in the early stage of colorectal cancer, and it is also implicated in alteration of mtDNA content in cancer cells.

[1]  S. Yorifuji,et al.  [Deletions of mitochondrial DNA in Kearns-Sayre syndrome]. , 1993, Nihon rinsho. Japanese journal of clinical medicine.

[2]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[3]  Tao Chen,et al.  Evaluating mitochondrial DNA in cancer occurrence and development , 2010, Annals of the New York Academy of Sciences.

[4]  P. Mecocci,et al.  Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Yau-Huei Wei,et al.  Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. , 2006, Biochimica et biophysica acta.

[6]  M. Spitz,et al.  Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. , 2008, Journal of the National Cancer Institute.

[7]  H. C. Lee,et al.  Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma , 2004, British Journal of Cancer.

[8]  S. Dimauro,et al.  Mitochondrial DNA Mutations and Pathogenesis , 1997, Journal of bioenergetics and biomembranes.

[9]  Pen-Hui Yin,et al.  Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers , 2005, Annals of the New York Academy of Sciences.

[10]  A. Cheung,et al.  The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. , 2005, Gynecologic oncology.

[11]  P. Beaune,et al.  Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[13]  Marty C. Brandon,et al.  Mitochondrial mutations in cancer , 2006, Oncogene.

[14]  A. Harding,et al.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies , 1988, Nature.

[15]  Analysis of mitochondrial DNA mutations in D-loop region in thyroid lesions. , 2010, Biochimica et biophysica acta.

[16]  B. Bainbridge,et al.  Genetics , 1981, Experientia.

[17]  Yi Wang,et al.  BMC Medical Genetics , 2007 .

[18]  Association of decreased mitochondrial DNA content with ovarian cancer progression , 2006, British Journal of Cancer.

[19]  Yidong Bai,et al.  Number matters: control of mammalian mitochondrial DNA copy number. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[20]  S. Sukumar,et al.  Tumor‐specific changes in mtDNA content in human cancer , 2005, International journal of cancer.

[21]  Yau-Huei Wei,et al.  Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.

[22]  Wanqing Chen,et al.  [Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002]. , 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[23]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[24]  D. Wallace.  Mitochondria as Chi , 2008, Genetics.

[25]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer , 2005, Genes, chromosomes & cancer.

[26]  Yidong Bai,et al.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis , 2009, Cell Research.

[27]  D. Wallace,et al.  Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[29]  P. Sheard,et al.  Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. , 1998, European journal of biochemistry.

[30]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer , 2005, Genes, chromosomes & cancer.

[31]  C. Meissner,et al.  The 4977bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: A useful biomarker or more? , 2008, Experimental Gerontology.

[32]  J. Califano,et al.  Mitochondrial DNA Quantity Increases with Histopathologic Grade in Premalignant and Malignant Head and Neck Lesions , 2004, Clinical Cancer Research.

[33]  Charles Swanton,et al.  Genetic prognostic and predictive markers in colorectal cancer , 2011, Nature Reviews Cancer.

[34]  S. Naylor,et al.  A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. , 2009, Human molecular genetics.

[35]  G. Dionigi,et al.  Genetic alteration in hereditary colorectal cancer. , 2007, Surgical oncology.

[36]  D. Wallace,et al.  Mitochondrial DNA mutations in human degenerative diseases and aging. , 1995, Biochimica et biophysica acta.

[37]  The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. , 2003, Medical hypotheses.

[38]  S. Weinhouse.  On respiratory impairment in cancer cells. , 1956, Science.

[39]  Jia Wei,et al.  Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease , 2011, Journal of Cancer Research and Clinical Oncology.

[40]  A. Chatterjee,et al.  Mitochondrial DNA mutations in human cancer , 2006, Oncogene.

[41]  Tao Chen,et al.  Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer , 2010, BMC Cancer.

[42]  D. Wallace,et al.  Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. , 1996, Biochimica et biophysica acta.

[43]  Laura C. Greaves,et al.  Mitochondrial DNA mutations in human disease , 2006, IUBMB life.

[44]  F. Chan,et al.  Asia Pacific consensus recommendations for colorectal cancer screening , 2008, Gut.

[45]  N. Avadhani,et al.  Mitochondrial signaling: the retrograde response. , 2004, Molecular cell.

[46]  E. Schon,et al.  Mitochondrial genetics and disease. , 2000, Trends in biochemical sciences.